HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 18.6

Change

+4.03 (+27.66)%

Market Cap

USD 2.64B

Volume

0.07B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-20 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
PG Procter & Gamble Company

N/A

USD 390.20B
UL Unilever PLC ADR

N/A

USD 136.18B
CL Colgate-Palmolive Company

N/A

USD 76.27B
KMB Kimberly-Clark Corporation

N/A

USD 45.08B
EL Estee Lauder Companies Inc

N/A

USD 44.23B
CHD Church & Dwight Company Inc

N/A

USD 26.24B
CLX The Clorox Company

N/A

USD 16.34B
ELF ELF Beauty Inc

N/A

USD 10.71B
COTY Coty Inc

N/A

USD 9.16B
SPB Spectrum Brands Holdings Inc

N/A

USD 2.62B

ETFs Containing HIMS

EDOC:LSE Global X Telemedicine & D.. 4.27 % 0.00 %

N/A

USD 4.69M
EDOG:LSE Global X Telemedicine & D.. 4.27 % 0.00 %

N/A

USD 0.07M
FDOC:LSE Fidelity Digital Health U.. 3.13 % 0.00 %

N/A

USD 4.68M
IBUY Amplify Online Retail ETF 3.04 % 0.65 %

N/A

USD 0.17B
WELP:LSE HAN-GINS Indxx Healthcare.. 2.48 % 0.00 %

N/A

USD 0.02B
XHS SPDR® S&P Health Care Se.. 2.26 % 0.35 %

N/A

USD 0.08B
W311:F HAN-GINS Indxx Healthcare.. 1.57 % 0.00 %

N/A

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 1.57 % 0.00 %

N/A

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 1.57 % 0.00 %

N/A

N/A
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

N/A

USD 0.02B
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 108.99% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 108.99% 82% B 99% N/A
Trailing 12 Months  
Capital Gain 95.79% 100% F 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 95.79% 100% F 97% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.09% 76% C+ 72% C
Dividend Return 11.09% 71% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 54.59% 18% F 16% F
Risk Adjusted Return 20.31% 41% F 42% F
Market Capitalization 2.64B 41% F 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.